Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Yichang Hec Changjiang Pharm
1558YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. The company's products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. Address: No. 38, Binjiang Road, Yichang, China
Analytics
Preço Alvo de Wall Street
120.27 HKDRácio P/E
4.3971Rendimento de dividendos
–Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 1558
Análise de Dividendos 1558
Crescimento de dividendos em 5 anos
–Crescimento contínuo
–Taxa de pagamento em média de 5 anos
44 %Histórico de Dividendos 1558
Avaliação de ações 1558
Relatório 1558
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |